玩股撇步(動畫小學堂)  

  • 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
  • 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近8季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益率 QoQ YoY稅後淨利率 QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
26Q1 (8)860.00.00.605.2681.820.6414.2982.860.60-72.9781.825.19-4.957.6851.87-0.92-4.6916.0320.9836.319.9611.9169.970.8315.2845.610.526.1285.7115.5215.2236.989.9611.9169.97-1.16-14.98-8.29
25Q4 (7)860.00.00.57-35.2350.00.56-30.8647.372.2234.5553.15.462.634.452.35-7.263.1113.25-29.1828.028.90-37.1941.720.72-28.033.330.49-34.6748.4813.47-31.4928.98.90-37.1941.724.0932.39-3.12
25Q3 (6)860.00.00.88100.0175.00.8124.6297.561.65114.2954.215.325.566.1956.455.879.2718.7118.7961.5714.1787.93156.241.026.5872.410.7597.37167.8619.6661.5491.9914.1787.93156.245.0666.6655.16
25Q2 (5)860.00.00.4433.3391.30.6585.71195.450.77133.332.675.044.56-0.453.32-2.021.5415.7533.93112.847.5428.6789.920.7938.6113.510.3835.7190.012.177.4161.627.5428.6789.92--0.00
25Q1 (4)860.00.00.33-13.160.00.35-7.890.00.33-77.240.04.82-7.840.054.427.190.011.7613.620.05.86-6.690.00.575.560.00.28-15.150.011.338.420.05.86-6.690.0--0.00
24Q4 (3)860.00.00.3818.750.00.38-7.320.01.4535.510.05.234.390.050.77-1.720.010.35-10.620.06.2813.560.00.54-6.90.00.3317.860.010.452.050.06.2813.560.0--0.00
24Q3 (2)860.00.00.3239.130.00.4186.360.01.0742.670.05.01-0.990.051.66-1.620.011.5856.490.05.5339.290.00.5856.760.00.2840.00.010.2435.990.05.5339.290.0--0.00
24Q2 (1)860.00.00.230.00.00.220.00.00.750.00.05.060.00.052.510.00.07.400.00.03.970.00.00.370.00.00.20.00.07.530.00.03.970.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2026/41.45-3.476.986.647.655.27N/A-
2026/31.5-35.617.125.197.845.191.08-
2026/22.3370.09-4.463.694.485.491.02-
2026/11.37-23.9824.271.3724.275.491.03-
2025/121.8-22.5514.8820.631.665.461.04-
2025/112.3273.65-1.3318.830.555.021.13-
2025/101.34-1.432.6216.510.825.211.09-
2025/91.36-45.973.6515.170.675.321.06-
2025/82.5173.454.5513.810.385.341.05-
2025/71.454.82-4.8311.3-0.495.131.09-
2025/61.38-40.09.959.850.175.041.09-
2025/52.370.41-1.68.47-1.254.931.11-
2025/41.355.678.86.17-1.125.071.08-
2025/31.28-47.474.664.82-3.594.821.12-
2025/22.44121.246.83.54-6.265.11.06-
2025/11.1-29.73-26.241.1-26.245.021.08-
2024/121.57-33.4813.8920.37.855.231.01-
2024/112.3680.61-5.7818.737.374.971.06-
2024/101.3-0.44-7.6216.379.575.021.05-
2024/91.31-45.513.2215.0711.375.241.03-
2024/82.457.87-1.513.7611.195.181.04-
2024/71.5221.1132.4811.3614.325.121.05-
2024/61.26-46.31-0.069.8411.944.841.1-
2024/52.3488.443.98.5813.954.811.11-
2024/41.241.654.446.2418.244.741.12-
2024/31.22-46.391.524.9922.264.99N/A-
2024/22.2852.7715.083.7730.935.15N/A-
2024/11.498.5165.81.4965.85.37N/A主要係去年1月春節假期9天,實際工作天少;另逢1月流感季節,客戶對本公司產品需求大增,致合併營收較去年同期增加。
2023/121.38-44.975.4418.82-21.545.29N/A-
2023/112.577.0910.7917.44-23.095.07N/A-
2023/101.4122.0326.3914.94-26.845.01N/A-
2023/91.16-52.6-26.2313.53-29.914.75N/A-
2023/82.44112.36-29.3612.38-30.244.85N/A-
2023/71.15-8.64-27.869.94-30.454.66N/A-
2023/61.26-44.18-48.178.79-30.784.7N/A-
2023/52.2589.42-41.997.53-26.674.65N/A-
2023/41.19-1.18-35.225.27-17.344.37N/A-
2023/31.2-39.23-14.134.09-10.124.09N/A-
2023/21.98120.11.762.88-8.334.19N/A-
2023/10.9-30.98-24.770.9-24.774.46N/A-
2022/121.3-42.18-6.5623.9926.164.68N/A-
2022/112.26102.027.4422.6828.754.94N/A-
2022/101.12-28.77-2.8820.4331.646.14N/A-
2022/91.57-54.6111.3319.3134.46.62N/A-
2022/83.45116.8858.7717.7436.917.47N/A主係檢驗試劑部門和其他部門之產品,市場需求增加,致整體營收增加。
2022/71.59-34.36-6.8114.2932.57.9N/A-
2022/62.43-37.5235.1112.6939.918.15N/A-
2022/53.88111.5152.7810.2741.097.12N/A主係檢驗試劑部門和其他部門之產品,市場需求增加,致整體營收增加。
2022/41.8430.9884.866.3834.815.19N/A主係檢驗試劑部門和其他部門之產品,市場需求增加,致整體營收增加。
2022/31.4-27.9826.684.5521.524.55N/A-
2022/21.9562.6915.263.1419.354.54N/A-
2022/11.2-14.2726.671.226.674.69N/A-
2021/121.4-33.52-18.8919.0121.24.65N/A-
2021/112.182.6-1.8517.6226.144.66N/A-
2021/101.15-18.34-0.115.5231.24.73N/A-
2021/91.41-35.279.0414.3734.585.29N/A-
2021/82.1827.2931.0712.9638.15.68N/A-
2021/71.71-4.8366.0110.7839.616.05N/A主係新冠肺炎疫情,檢驗試劑及感控部門之產品,市場需求增加,及新併入之子公司營收,致整體營收增加。
2021/61.8-29.34125.59.0735.540.0N/A主係新冠肺炎疫情,檢驗試劑及感控部門之產品,市場需求增加,致整體營收增加。
2021/52.54155.9267.327.2823.390.0N/A主係新冠肺炎疫情,檢驗試劑及感控部門之產品,市場需求增加,致整體營收增加。
成長能力-近5年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益率 YoY稅後淨利率 YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2025 (5)860.02.2152.412.3780.9220.631.6354.132.6614.9247.299.2250.163.0849.512.9435.481.952.0
2024 (4)860.01.4561.111.3172.3720.37.8652.731.8310.1321.616.1449.762.0631.212.1728.41.2562.34
2023 (3)860.00.90-57.550.76-75.1618.82-21.5551.78-5.88.33-51.744.10-46.051.57-62.081.69-49.250.77-57.69
2022 (2)868.862.1260.613.06202.9723.9926.254.9714.5717.2698.397.6038.434.14150.913.3381.971.8275.0
2021 (1)792.61.32266.671.01102.019.0121.1647.9808.7005.4901.6557.141.83105.621.04271.43

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。